AstraZeneca teams up with startup Quell in type 1 diabetes, IBD cell therapy pact— Activist shareholders blast Merck's IRA lawsuit, urge company to reconsider --FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV -- See more on our front page news